Yabao Pharmaceutical Group Co. Ltd. provided earnings guidance for the full year of 2017. For the year, the company expects the net profit owned by shareholders will increase by between RMB 177.47 million and RMB 184.3 million, with an increase of between 788% and 818% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders after excluding extraordinary profit and loss will increase by between RMB 250.6 million and RMB 257.43 million compared with the same period of the year before (based on the disclosed statistics according to relevant regulations).